Navigation Links
Array BioPharma Announces Proposed Public Offering of Convertible Debt
Date:6/3/2013

BOULDER, Colo., June 3, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that it plans to offer, subject to market and other conditions, convertible senior notes due 2020 of approximately $100 million in aggregate principal amount in an underwritten public offering pursuant to an effective shelf registration statement on Form S-3. Array expects to grant the underwriters a 30-day option to purchase up to approximately an additional $15 million in aggregate principal amount of convertible senior notes in connection with the offering. Prior to March 1, 2020, the notes will be convertible only upon certain circumstances and during certain periods. Upon conversion, the holders will receive, at Array's option, shares of Array's common stock, cash or a combination of shares and cash. Goldman, Sachs & Co. and J.P. Morgan Securities LLC are acting as joint book-running managers for the offering.

(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)

The notes will be general senior unsecured obligations of Array and will pay interest semi-annually. The principal amount, interest rate, conversion rate, offering price and other terms will be determined at the time of pricing of the offering. Array expects to use approximately $92.6 million of the net proceeds to repay its outstanding secured indebtedness, with the remaining proceeds expected to be used for general corporate purposes.

The convertible senior notes will be offered and sold under Array's shelf registration statement filed with the Securities and Exchange Commission ("SEC") on June 3, 2013, which was effective upon filing.  Before you invest in the convertible senior notes, you should read the prospectus and accompanying preliminary prospectus relating to the offering an
'/>"/>

SOURCE Array BioPharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Two Array Invented MEK Inhibitors Showcased At ASCO
2. Array BioPharma To Present At The Jefferies 2013 Global Healthcare Conference
3. Oncothyreon and Array Announce Collaboration to Develop and Commercialize anti-HER2 Compound ARRY-380
4. Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO Annual Meeting
5. Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer
6. Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013
7. New Versa HD System Tops Elektas Comprehensive Array of Cancer Management Solutions at 2nd ESTRO Forum
8. Array BioPharma Announces Updates on ARRY-520 Clinical Data at the 2013 International Myeloma Workshop
9. Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
10. Array BioPharma To Present At The Cowen Annual Health Care Conference
11. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 24, 2014 LifeScienceIndustryResearch.com ... Disposable Syringe Industry of 178 pages providing ... intelligence library. The 2014 Market ... is a professional and deep research report ... analysis, the report introduces Disposable Syringe basic ...
(Date:12/24/2014)...  The American Diabetes Association is recommending a ... with diabetes and that all people with diabetes ... in keeping with recent changes to guidelines for ... of Cardiology (ACC) and American Heart Association (AHA). ... changes to the Association,s annual revised Standards of ...
(Date:12/24/2014)... HILL, N.C. , Dec. 23, 2014  Medical ... success. As the key link between the medical device ... grow even more in the coming years as the ... According to research by benchmarking firm, ... MSLs can gain an important edge is by harnessing ...
Breaking Medicine Technology:World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4Role of Medical Science Liaisons Evolving in Medical Device Sector 2
... Life Sciences, Inc. (Nasdaq: CALP ), a ... and life sciences research, today announced that the company ... for the Environmental Protection Agency,s (EPA) Phase II ToxCast™ ... Protection Agency (EPA) announced the next phase of toxicity ...
... 2010 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ... diseases associated with inflammation, today announced that their product ... Pediatric Research Award at the Third Congress of the ... where Dr. Daniele De Luca, MD, PhDst at the ...
Cached Medicine Technology:Caliper Continues Participation in EPA's Expanded ToxCast Program; Receives Remaining Phase II Compounds for Screening in Fourth Quarter 2Caliper Continues Participation in EPA's Expanded ToxCast Program; Receives Remaining Phase II Compounds for Screening in Fourth Quarter 3Varespladib Receives 2010 European Society Pediatric Research Award 2Varespladib Receives 2010 European Society Pediatric Research Award 3
(Date:12/25/2014)... Dallas, TX (PRWEB) December 26, 2014 ... current state of the global Sterilizers industry with a ... statistics on the market status of the Sterilizers manufacturers ... for companies and individuals interested in the industry. This ... its definition, applications and manufacturing technology. In this part, ...
(Date:12/25/2014)... three months the trends for evening dresses shift ... one of the hottest styles in the next few months.” ... releases 26 A-line sweetheart evening dresses, and announces the availability ... are trying our best to help a lady to show ... affordable prices, we provide discounted delivery costs to our customers ...
(Date:12/25/2014)... BambooFlooringChina.com sells many bamboo products and the business ... company announces big discounts on its bamboo mats ... BambooFlooringChina.com is the world’s leader in bamboo flooring. According ... Jan. 20, 2015. , The bamboo mats are made ... thread. All the bamboo strips for the mats are ...
(Date:12/25/2014)... 25, 2014 (HealthDay News) -- The risk of burns ... so you need to be extra cautious, an expert ... see a significant increase in patients coming in with ... Suffolk County Volunteer Firefighters Burn Center of Stony Brook ... be full of joy, but if not careful, could ...
(Date:12/25/2014)... New York (PRWEB) December 25, 2014 ... continue to move forward in a number of multidistrict ... of West Virginia, Bernstein Liebhard LLP reports. According to ... is scheduled to convene a Joint Status Conference in ... 10:00 a.m. Parties have been directed to submit a ...
Breaking Medicine News(10 mins):Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4
... The University of Colorado Cord Blood Bank, a component ... Medicine, has been awarded $6.3 million to collect and bank ... groups. The three-year grant is from the Health ... Department of Health and Human Services. Umbilical cord blood, collected ...
... back to the cancer communities in the cities visited ... Radiation Oncology (ASTRO) is partnering with the Emilio Nares ... survivorship issues., "When a child has cancer the entire ... a radiation oncologist at Massachusetts General Hospital, said. "The ...
... Hospital study has demonstrated how the hospital has improved patient ... transfusions. In 2009, the average amount of blood products transfused ... was in 2008, saving $453,355. The average amount of blood ... to 1.82 units per patient in 2009. Results were reported ...
... National Institute of Allergy and Infectious Diseases (NIAID), part ... new contracts to fund research on vaccines to protect ... be used in a terror attack. Each project focuses ... be deployed quickly. The total funding for the three ...
... HealthDay Reporter , WEDNESDAY, Oct. 6 (HealthDay News) -- A ... plus kidney failure did not show any overall benefit, indicating that ... "I think this is the end of the story for this ... in the Oct. 7 issue of the New England Journal ...
... 2010) To mark World Menopause Day on 18th ... new Recommendations for the management of postmenopausal vaginal atrophy, ... of women after menopause. This new guidance is ... women with vaginal atrophy (VA) will live with their ...
Cached Medicine News:Health News:University of Colorado gets federal award for Cord Blood Bank 2Health News:Reducing blood transfusions improves patient safety and cuts costs 2Health News:NIH funds advanced development of 3 biodefense vaccines 2Health News:NIH funds advanced development of 3 biodefense vaccines 3Health News:Once-Promising Heart Failure Drug Fails in Trial 2Health News:International Menopause Society calls upon medical community to improve the vaginal health of postmenopausal women 2Health News:International Menopause Society calls upon medical community to improve the vaginal health of postmenopausal women 3
The INSIGNIA® pacing systems allow the physician to provide customized adaptive-rate pacing therapy to meet individual patient needs....
The Guidant INSIGNIA Ultra pacing system offers sophisticated patient-specific, easy-to-use features for simplified patient management and enhanced patient safety....
... small portable unit weighing less than thirty ... dependability and uncompromising image quality. Compatible with ... is a cost effective solution for a ... keyboard is durable and easy to operate. ...
The EUB-525 is a mid-size system with a full feature set. Capable of B-mode, M-mode, Doppler, Color Flow and Color Angiography it performs a variety of tasks in a simple and straightforward fashion....
Medicine Products: